
Opinion|Videos|March 14, 2025
Recent Medical Advancements: Opportunities and Considerations
Author(s)Daniel E. Kremens, MD, JD
An expert discusses the extended form of carbidopa/levodopa (Crexont) for managing OFF episodes, highlighting trial results that show decreased OFF time and increased ON time, as well as the use of subcutaneous loading of medications in Parkinson disease, which was well tolerated with skin issues as the main adverse effects and resulted in increased ON time without worsening dyskinesia.
Advertisement
Episodes in this series

Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Anti-IL6R Therapy Effective in Reducing NMOSD and MOGAD Disease Activity
2
Phase 3 EMBARK Data Released, CTE Associated with Dementia Risk, Pilavapadin Heads to Phase 3 Pain Studies
3
VMAT2 Inhibitor NBI-1065890 Heads to Phase 2 Study in Tardive Dyskinesia
4
Taysha Doses First Patient in Pivotal Trial for Rett Syndrome Gene Therapy TSHA-102, Aligns With FDA on BLA Plans
5











